Fish oil was effective in fructose-induced NAFLD, and it also inhibited hepatic lipogenesis, increased hepatic β-oxidation, and improved insulin sensitivity [83,84]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.